Radiation therapy Global Market – Forecast To 2024

Publishing Date : December, 2017
Report Code : HCMD0153
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances, such as radioactive iodine, that travel in the blood to kill cancer cells. About half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Radiation therapy is sometimes given with curative intent. In such cases, radiation therapy may be used alone or in combination with surgery, chemotherapy, or both. It may also be given with palliative intent, which is not intended to cure; instead they relieve symptoms and reduce the suffering caused by cancer. For example, radiation given to the brain to shrink tumours formed from cancer cells that have spread to the brain from another part of the body. Radiation therapy kills cancer cells either by damaging DNA directly or creates charged particles (free radicals) within the cells that can in turn damage the DNA, but does not travel throughout the body as chemotherapy treatment does. But, it can cause side effects, damaging healthy cells and tissues surrounding the tumour cells, in turn can also damage the surrounding organs and it may also leads to develop a secondary cancer as a result of exposure to radiation. Today, major advances in radiation technology have made it more precise, leading to fewer side effects with the modern ways of giving radiation therapy and careful treatment planning aim to reduce the risk of these complications. The radiation therapy global market is expected to grow at mid single digit CAGR to reach 8,680.6 million by 2024.

The radiation therapy market is segmented based on their products, technology, end-users and geography. The radiation therapy market by products is segmented into external radiation therapy products, internal radiation therapy products and systemic radiation therapy products. The external radiation therapy products are further segmented into Linear accelerators (Linacs) and proton therapy systems. The internal radiation therapy product is further segmented into seeds, applicators & afterloaders, others (electronic brachytherapy & accessories) and systemic radiation therapy products are further segmented into alpha emitters and beta emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into Stereotactic radio surgery (SRS), Stereotactic body radiation therapy (SBRT), Image-guided radiation therapy (IGRT), Intensity-modulated radiation therapy (IMRT); Volumetric modulated arc therapy (VMAT), Intensity-modulated proton therapy (IMPT) and others. Internal radiation therapy technology is further segmented into High dose rate brachytherapy, low dose rate brachytherapy and others. Based on applications, radiation therapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, gastrointestinal cancer, lung cancer, brain cancer, head & neck cancer and others. Based on end-users, radiation therapy market is segmented into hospitals, radiation therapy centres, ambulatory surgical centres and others. Further the radiation therapy global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. North America is further segmented into U.S. and Others. Europe is further segmented into Germany, Italy, France, and others. Asia-pacific region is further segmented into China, Japan, India and others and Rest of the world is further segmented into Brazil, Rest of Latin America and Middle East & Others.

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
    • 3.4     MARKET DYNAMICS
      • 3.4.1     DRIVERS AND OPPORTUNITIES
        • 3.4.1.1     GROWING PREVALENCE OF CANCER CASES
        • 3.4.1.2     ADOPTION OF UNHEALTHY LIFESTYLE
        • 3.4.1.3     TECHNOLOGICAL ADVANCEMENTS
        • 3.4.1.4     RISING PREFERENCE FOR NON-INVASIVE PROCEDURES OF CANCER TREATMENT
        • 3.4.1.5     RAPID RISE IN GERIATRIC POPULATION
      • 3.4.2     RESTRAINTS AND THREATS
        • 3.4.2.1     SIDE EFFECTS ASSOCIATED WITH THE RADIATION THERAPY
        • 3.4.2.2     LACK OF SUFFICIENT INFRASTRUCTURE AND SKILLED TECHNICIANS IN LOW AND MIDDLE INCOME COUNTRIES
        • 3.4.2.3     LACK OF AWARENESS AND UNDERSTANDING ABOUT RADIATION THERAPY’S IMPORTANCE
        • 3.4.2.4     HIGH COST OF RADIATION THERAPY DEVICES
        • 3.4.2.5     STRINGENT REGULATORY REQUIREMENTS
    • 3.5     REGULATORY AFFAIRS
      • 3.5.1     U.S.
      • 3.5.2     EUROPE
      • 3.5.3     CHINA
      • 3.5.4     INDIA
      • 3.5.5     JAPAN
    • 3.6     REIMBURSEMENT SCENARIO
      • 3.6.1     REIMBURSEMENT TABLE
    • 3.7     CLINICAL TRIAL DATA
    • 3.8     PATENT TRENDS
    • 3.9     TECHNOLOGICAL ADVANCEMENTS
      • 3.9.1     INTRODUCTION
        • 3.9.1.1     ADVANCEMENTS IN LINEAR ACCELERATOR TECHNOLOGY
        • 3.9.1.2     MRI-GUIDED RADIATION THERAPY
        • 3.9.1.3     PROTON THERAPY
    • 3.10     FUNDING SCENARIO
    • 3.11     PORTER’S FIVE FORCE ANALYSIS
      • 3.11.1     THREAT OF NEW ENTRANTS
      • 3.11.2     THREAT OF SUBSTITUTES
      • 3.11.3     BARGAINING POWER OF SUPPLIERS
      • 3.11.4     BARGAINING POWER OF BUYERS
      • 3.11.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.12     SUPPLY CHAIN ANALYSIS
    • 3.13     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.13.1     MARKET SHARE ANALYSIS OF LINAC BY MAJOR PLAYERS
      • 3.13.2     LINAC INSTALLED BASE GLOBAL MARKET SHARE, BY REGION
      • 3.13.3     MARKET SHARE ANALYSIS OF PROTON THERAPY SYSTEMS BY MAJOR PLAYERS
      • 3.13.4     MARKET SHARE ANALYSIS OF BRACHYTHERAPY BY MAJOR PLAYERS
      • 3.13.5     BRACHYTHERAPY INSTALLED BASE GLOBAL MARKET SHARE, BY REGION
      • 3.13.6     MARKET SHARE ANALYSIS OF ELECTRONIC BRACHYTHERAPY, BY MAJOR PLAYERS
  • 4     RADIATION THERAPY GLOBAL MARKET, BY PRODUCT TYPE
    • 4.1     INTRODUCTION
    • 4.2     EXTERNAL BEAM RADIATION THERAPY
      • 4.2.1     LINEAR ACCELERATORS (LINACS)
      • 4.2.2     PROTON THERAPY SYSTEMS
    • 4.3     INTERNAL RADIATION THERAPY
      • 4.3.1     SEEDS
      • 4.3.2     APPLICATORS & AFTERLOADERS
      • 4.3.3     OTHERS (ELECTRONIC BRACHYTHERAPY & ACCESSORIES)
    • 4.4     SYSTEMIC RADIATION THERAPY
      • 4.4.1     ALPHA EMITTERS
      • 4.4.2     BETA EMITTERS
  • 5     RADIATION THERAPY GLOBAL MARKET, BY TECHNOLOGY
    • 5.1     INTRODUCTION
    • 5.2     EXTERNAL RADIATION THERAPY
      • 5.2.1     IMAGE-GUIDED RADIATION THERAPY (IGRT)
      • 5.2.2     INTENSITY-MODULATED RADIATION THERAPY (IMRT)
      • 5.2.3     VOLUMETRIC MODULATED ARC THERAPY (VMAT)
      • 5.2.4     STEREOTACTIC BODY RADIATION THERAPY (SBRT)
      • 5.2.5     STEREOTACTIC RADIOSURGERY (SRS)
      • 5.2.6     INTENSITY MODULATED PROTON THERAPY (IMPT)
      • 5.2.7     OTHER EXTERNAL RADIATION THERAPIES
    • 5.3     INTERNAL RADIATION THERAPY
      • 5.3.1     HIGH DOSE RATE (HDR) BRACHYTHERAPY
      • 5.3.2     LOW DOSE RATE (LDR) BRACHYTHERAPY
      • 5.3.3     OTHER INTERNAL RADIATION THERAPIES
    • 5.4     SYSTEMIC RADIATION THERAPY
  • 6     RADIATION THERAPY GLOBAL MARKET BY APPLICATIONS
    • 6.1     INTRODUCTION
      • 6.1.1     PROSTATE CANCER
      • 6.1.2     GYNAECOLOGY CANCERS
      • 6.1.3     BREAST CANCER
      • 6.1.4     HEAD & NECK CANCER
      • 6.1.5     LUNG CANCER
      • 6.1.6     BRAIN CANCER
      • 6.1.7     GASTROINTESTINAL CANCER
      • 6.1.8     OTHERS
  • 7     RADIATION THERAPY GLOBAL MARKET, BY END-USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     AMBULATORY SURGICAL CENTRES
    • 7.4     RADIATION THERAPY SPECIALITY CENTRES
    • 7.5     OTHERS
  • 8     REGIONAL ANALYSIS
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
      • 8.2.1     U.S.
      • 8.2.2     OTHERS
    • 8.3     EUROPE
      • 8.3.1     GERMANY
      • 8.3.2     ITALY
      • 8.3.3     FRANCE
      • 8.3.4     OTHERS
    • 8.4     ASIA PACIFIC (APAC)
      • 8.4.1     CHINA
      • 8.4.2     JAPAN
      • 8.4.3     INDIA
      • 8.4.4     OTHERS
    • 8.5     REST OF THE WORLD (ROW)
      • 8.5.1     BRAZIL
      • 8.5.2     REST OF LATIN AMERICA
      • 8.5.3     MIDDLE EAST AND OTHERS
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS
    • 9.3     APPROVALS
    • 9.4     NEW PRODUCT LAUNCH
    • 9.5     ACQUISITIONS
    • 9.6     OTHER DEVELOPMENTS
  • 10     MAJOR COMPANIES
    • 10.1     ACCURAY, INCORPORATED
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     BAYER AG
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     BRAINLAB AG
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     C.R.BARD INC.
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     CARL ZEISS MEDITEC AG
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     ECKERT & ZIEGLER BIBEG
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     ELEKTA AB
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     HITACHI MEDICAL CORPORATION
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     IBA (ION BEAM APPLICATIONS S.A.)
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     MEVION MEDICAL SYSYTEMS.
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS
    • 10.11     RAYSEARCH LABORATORIES INC.,
      • 10.11.1     OVERVIEW
      • 10.11.2     FINANCIALS
      • 10.11.3     PRODUCT PORTFOLIO
      • 10.11.4     KEY DEVELOPMENTS
      • 10.11.5     BUSINESS STRATEGY
      • 10.11.6     SWOT ANALYSIS
    • 10.12     VARIAN MEDICAL SYSTEMS, INC.
      • 10.12.1     OVERVIEW
      • 10.12.2     FINANCIALS
      • 10.12.3     PRODUCT PORTFOLIO
      • 10.12.4     KEY DEVELOPMENTS
      • 10.12.5     BUSINESS STRATEGY
      • 10.12.6     SWOT ANALYSIS
    • 10.13     VIEWRAY, INC.,
      • 10.13.1     OVERVIEW
      • 10.13.2     FINANCIALS
      • 10.13.3     PRODUCT PORTFOLIO
      • 10.13.4     KEY DEVELOPMENTS
      • 10.13.5     BUSINESS STRATEGY
      • 10.13.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
      • TABLE 2     RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
      • TABLE 3     EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 4     EXTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 5     LINEAR ACCELERATORS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 6     LINEAR ACCELERATORS NO. OF UNITS, BY REGION (2016-2024)
      • TABLE 7     PROTON THERAPY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 8     INTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 9     INTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY TYPE (2016-2024) ($MN)
      • TABLE 10     SEEDS GLOBAL MARKET REVENUE,BY REGION (2016-2024) ($MN)
      • TABLE 11     APPLICATORS, & AFTERLOADERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 12     OTHER (ELECTRONIC BRACHYTHERAPY & ACCESSORIES) PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 13     SYSTEMIC RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 14     SYSTEMIC RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 15     ALPHA EMITTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 16     BETA EMITTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 17     RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
      • TABLE 18     EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 19     EXTERNAL RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 20     IGRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 21     IMRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 22     VMAT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 23     SBRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 24     SRS TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 25     IMPT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 26     OTHER EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 27     INTERNAL RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 28     INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 29     HDR TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 30     LDR TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 31     OTHER INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 32     SYSTEMIC RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 33     RADIATION THERAPY GLOBAL MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
      • TABLE 34     PROSTATE CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 35     GYNAECOLOGY CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 36     BREAST CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 37     HEAD & NECK CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 38     LUNG CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 39     BRAIN CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 40     GASTROINTESTINAL CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 41     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 42     RADIATION THERAPY GLOBAL MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
      • TABLE 43     RADIATION THERAPY HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 44     RADIATION THERAPY AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 45     RADAIATION THERAPY SPECIALITY CENTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 46     RADIATION THERAPY OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 47     RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • TABLE 48     NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
      • TABLE 49     NORTH AMERICA EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 50     NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
      • TABLE 51     NORTH AMERICA INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 52     NORTH AMERICA EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 53     NORTH AMERICA INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 54     NORTH AMERICA SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 55     NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
      • TABLE 56     NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
      • TABLE 57     NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY COUNTRY (2016-2024) ($MN)
      • TABLE 58     EUROPE RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
      • TABLE 59     EUROPE EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 60     EUROPE INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 61     EUROPE RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
      • TABLE 62     EUROPE EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 63     EUROPE INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 64     EUROPE SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 65     EUROPE RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
      • TABLE 66     EUROPE RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
      • TABLE 67     EUROPE RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 68     APAC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
      • TABLE 69     APAC EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 70     APAC INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 71     APAC SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 72     APAC RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
      • TABLE 73     APAC EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 74     APAC INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 75     APAC RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
      • TABLE 76     APAC RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
      • TABLE 77     APAC RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 78     ROW RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
      • TABLE 79     ROW EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 80     ROW INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 81     ROW SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
      • TABLE 82     ROW RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
      • TABLE 83     ROW EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 84     ROW INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
      • TABLE 85     ROW RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
      • TABLE 86     ROW RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
      • TABLE 87     ROW RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
      • TABLE 88     AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, (2016-2017)
      • TABLE 89     APPROVALS, (2016-2017)
      • TABLE 90     NEW PRODUCT LAUNCH, (2016-2017)
      • TABLE 91     ACQUISITIONS, (2016-2017)
      • TABLE 92     OTHER DEVELOPMENTS (2016-2017)
      • TABLE 93     ACCURAY, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 94     ACCURAY, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 95     ACCURAY, INC : TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 96     BAYER AG : TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 97     BAYER AG : TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 98     BAYER AG : TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 99     C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 100     C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 101     CARL ZEISS MEDITEC AG : TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 102     CARL ZEISS MEDITEC AG : TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 103     CARL ZEISS MEDITEC AG : TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 104     ECKERT & ZIEGLER GROUP : TOTAL REVENUE AND R&D EXPENSES, (2015 - 2017) ($MN)
      • TABLE 105     ECKERT & ZIEGLER GROUP : TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 106     ELEKTA AB : TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 107     ELEKTA AB : TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
      • TABLE 108     ELEKTA AB : TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 109     HITACHI MEDICAL CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 110     HITACHI MEDICAL CORPORATION : TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
      • TABLE 111     HITACHI MEDICAL CORPORATION : TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 112     IBA : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 113     IBA : TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 114     IBA : TOTAL REVENUE, BY PROTON THERAPY SEGMENT, (2014-2016) ($MN)
      • TABLE 115     IBA : TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
      • TABLE 116     RAYSEARCH LABORATORIES INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 117     RAYSERACH LABORATORIES : TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
      • TABLE 118     RAYSEARCH LABORATORIES : TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
      • TABLE 119     VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 120     VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 121     VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)

      LIST OF FIGURES

      • FIGURE 1     RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: RADIATION THERAPY GLOBAL MARKET
      • FIGURE 3     RADIATION THERAPY GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     RADIATION THERAPY GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     RADIATION THERAPY GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     RADIATION THERAPY GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     RADIATION THERAPY GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2012 TO 2017)
      • FIGURE 9     RADIATION THERAPY GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     RADIATION THERAPY GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     RADIATION THERAPY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 12     LINAC GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 2017 (%)
      • FIGURE 13     LINAC INSTALLED BASE GLOBAL MARKET SHARE ANALYSIS, BY REGION, 2017 (%)
      • FIGURE 14     LINACS GLOBAL INSTALL BASE OF KEY PLAYERS, BY REGION, 2017 (%)
      • FIGURE 15     PROTON THERAPY SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 16     BRACHYTHERAPY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
      • FIGURE 17     BRACHYTHERPAY INSTALLED BASE GLOBAL MARKET SHARE ANALYSIS, BY REGION, 2017 (%)
      • FIGURE 18     ELECTRONIC BRACHYTHERAPY MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 2017 (%)
      • FIGURE 19     RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
      • FIGURE 20     EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
      • FIGURE 21     INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
      • FIGURE 22     SYSTEMIC RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
      • FIGURE 23     RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2017 VS 2024) ($MN)
      • FIGURE 24     EXTERNAL RADIATION THERAPY GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE (2017 VS 2024) (%)
      • FIGURE 25     INTERNAL RADIATION THERAPY GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE (2017 VS 2024) (%)
      • FIGURE 26     RADIATION THERAPY GLOBAL MARKET SHARE, BY APPLICATIONS (2017 VS 2024) (%)
      • FIGURE 27     RADIATION THERAPY GLOBAL MARKET REVENUE, BY END-USERS (2017 VS. 2024) ($MN)
      • FIGURE 28     RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016 - 2024) ($MN), CAGR (%)
      • FIGURE 29     NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 30     NORTH AMERICA RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
      • FIGURE 31     U.S. RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 32     U.S. RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 33     OTHERS NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 34     OTHERS NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 35     EUROPE RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 36     EUROPE RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
      • FIGURE 37     GERMANY RADIATION THERAPY MARKET SHARE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 38     GERMANY RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 39     ITALY RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 40     ITALY RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 41     FRANCE RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 42     FRANCE RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 43     OTHER EUROPEAN COUNTRIES RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 44     OTHER EUROPEAN COUNTRIES RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 45     APAC RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 46     APAC RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
      • FIGURE 47     CHINA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 48     CHINA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 49     JAPAN RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 50     JAPAN RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 51     INDIA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 52     INDIA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 53     OTHER APAC COUNTRIES RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 54     OTHER APAC COUNTRIES RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 55     ROW RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 56     ROW RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
      • FIGURE 57     BRAZIL RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 58     BRAZIL RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 59     REST OF LATIN AMERICAN RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 60     REST OF LATIN AMERICAN RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 61     MIDDLE EAST & OTHERS RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
      • FIGURE 62     MIDDLE EAST & OTHERS RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
      • FIGURE 63     KEY GROWTH STRATEGIES, (2016-2017)
      • FIGURE 64     SWOT: ACCURAY, INC
      • FIGURE 65     SWOT: BAYER AG
      • FIGURE 66     SWOT: BRAINLAB
      • FIGURE 67     SWOT: C.R.BARD INC.
      • FIGURE 68     SWOT: CARL ZEISS MEDITEC AG
      • FIGURE 69     SWOT: ECKERT & ZIEGLER BEBIG GROUP
      • FIGURE 70     SWOT: ELEKTA
      • FIGURE 71     SWOT: HITACHI MEDICAL CORPORATION
      • FIGURE 72     SWOT: IBA (ION BEAM APPLICATIONS S.A.)
      • FIGURE 73     SWOT: MEVION MEDICAL SYSYTEMS INC.,
      • FIGURE 74     SWOT: RAYSEARCH LABORATORIES
      • FIGURE 75     SWOT: VARIAN MEDICAL SYSTEMS, INC.
      • FIGURE 76     SWOT: VIEWRAY INC.

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ACCSYS TECHNOLOGY INC.
      • 2     ACCURAY INC.
      • 3     ADVANCED RAD SOLUTIONS (ARS)
      • 4     ADVANCED MEDICAL ISOTOPE CORPORATION
      • 5     ANAZAO HEALTH CORPORATION
      • 6     ARIANE MEDICAL SYSTEMS
      • 7     ARPLAY MEDICAL
      • 8     ADVANCED MEDICAL ISOTOPE CORPORATION
      • 9     ANAZAO HEALTH CORPORATION
      • 10     ANTISOMA PLC LTD
      • 11     BIONUCLEONICS INC.,
      • 12     CIANNA MEDICAL
      • 13     CORE ONCOLOGY INC.,
      • 14     BAYER HEALTHCARE PHARMACEUTICALS LLC
      • 15     BIONIX
      • 16     BRAIN LAB, INC.
      • 17     BXTACCELYON LIMITED
      • 18     CARL ZEISS MEDITECH, INC.
      • 19     C.R. BARD INC
      • 20     CIRS
      • 21     CIVCO RADIATION THERAPY
      • 22     C-RAD AB
      • 23     DOSISOFT
      • 24     ECKERT & ZIEGLER BEBIG
      • 25     ELEKTA AB
      • 26     FILTRINE
      • 27     GE HEALTHCARE
      • 28     HAMMING
      • 29     HITACHI MEDICAL CORPORATION
      • 30     HOLOGIC INC
      • 31     HUIHENG MEDICAL
      • 32     ICAD, INC.
      • 33     IMPAC MEDICAL SYSTEMS
      • 34     INTRAOP MEDICAL CORPORATION
      • 35     ION BEAM APPLICATIONS (IBA)
      • 36     ISOAID
      • 37     ISORAY
      • 38     KLARITY MEDICAL
      • 39     LIONESS THERAPEUTICS
      • 40     MALLINCKRODT PHARMACEUTICALS
      • 41     MEVION MEDICAL SYSTEMS
      • 42     MITSUBISHI HEAVY INDUSTRIES
      • 43     MODUS QA
      • 44     NEUSOFT
      • 45     NORDION INC.
      • 46     NTP RADIOISOTOPES
      • 47     NUCLEONIX SYSTEMS PVT LTD.
      • 48     PHILIPS HEALTHCARE
      • 49     PROTOM INTERNATIONAL
      • 50     PROVISION HEALTHCARE
      • 51     RAYSEARCH LABORATORIES
      • 52     SENSUS HEALTHCARE
      • 53     SHINVA
      • 54     SIEMENS HEALTHCARE
      • 55     SIRTEX
      • 56     SUMITOMO HEAVY INDUSTRIES, LTD.
      • 57     TEAMBEST
      • 58     THERAGENICS CORPORATION
      • 59     TOP GRADE HEALTHCARE
      • 60     TOSHIBA
      • 61     TRAID ISOTOPES
      • 62     VARIAN MEDICAL SYSTEMS
      • 63     VIEWRAY INC.,
      • 64     XSTRAHL MEDICAL
      • 65     21ST CENTURY ONCOLOGY